Concepedia

Daniel Santos

DS

Statistics

Publications

16

Citations

1.4K

H-Index

16

Active since

2004

Affiliations

Dana-Farber Cancer Institute(Current)

Harvard University

Brigham and Women's Hospital

Democritus University of Thrace

VA Boston Healthcare System

Daniel Santos is an author at Dana-Farber Cancer Institute specializing in life sciences, immunology, and clinical immunology.

ORCID

Publications per year

2004–2009

16

Publications

16

Increased natural killer cell expression of CD16, augmented binding and ADCC activity to rituximab among individuals expressing the FcγRIIIa-158 V/V and V/F polymorphism

Evdoxia Hatjiharissi, Lian Xu, Daniel Santos et al. · Blood · 2007 · 266 citations · Full text

, , +17

Characterization of familial Waldenström's macroglobulinemia

Steven P. Treon, Zachary R. Hunter, Abha Aggarwal et al. · Annals of Oncology · 2005 · 190 citations

, , +6

Paradoxical increases in serum IgM and viscosity levels following rituximab in Waldenstrom's macroglobulinemia

Steven P. Treon, Andrew R. Branagan, Zachary R. Hunter et al. · Annals of Oncology · 2004 · 162 citations

, , +13

Human Anti-CD40 Antagonist Antibody Triggers Significant Antitumor Activity against Human Multiple Myeloma

Yu‐Tzu Tai, Xianfeng Li, Tong Xia et al. · Cancer Research · 2005 · 160 citations

, , +14

Mast cells in Waldenstrom's macroglobulinemia support lymphoplasmacytic cell growth through CD154/CD40 signaling

Olivier Tournilhac, Daniel Santos, Lian Xu et al. · Annals of Oncology · 2006 · 131 citations · Full text

, , +12

1–5 of 16